Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
fda
4
×
life sciences
medicare
4
×
national blog main
san diego blog main
4
×
san diego top stories
san francisco blog main
san francisco top stories
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
regeneron pharmaceuticals
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alex azar
biogen
biotech
eli lilly
startups
ucb
3d imaging
89bio
abbvie
adrian krainer
alexion pharmaceuticals
What
drug
4
×
prices
trump
administration
afternoon
alzheimer’s
angry
annual
anti
anticipated
assessed
attention
awaited
benefited
bio
biotech
blueprint
communities
conference
cost
cut
daunting
despite
details
developers
drugs
esmo
europe
fear
firms
germany
healthcare
hosted
house
industry
investment
long
losing
lower
markets
Language
Current search:
fda
×
drug
×
" san diego blog main "
×
medicare
×
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
